SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 5, 2025 at 4:00 PM Eastern Time. Following the announcement, …

… third quarter of 2025, reporting $11.12 billion in revenue and adjusted earnings … “quiet confidence” among pharma executives that they can … would actually shield drugmakers from Trump’s … companies building “their Pharmaceutical Manufacturing Plant in America …

… investors likely took some profits. With the major … have reported third-quarter earnings so far have surpassed profit estimates, on … Trump's pharma probe plan raises threat … Wall Street earnings on revenue for its third-quarter earnings report. Humana …

… dropped 10% after its third-quarter revenue missed expectations and … steep selloff, with profit-taking outweighing safe-haven … aluminium smelter, alongside quarterly earnings that reaffirmed its alumina … 3.62, and Telix Pharmaceuticals dosed the first patient …

Colgate-Palmolive Company (NYSE: CL) will provide a live webcast of its 2025 third-quarter earnings conference call on Friday, October 31, 2025, at 8:30 AM ET. The call will be hosted by Chairman, President and CEO Noel Wallace, Chief Financial Officer …

TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it has rescheduled its November 6, 2025 earnings …

… to scaling capabilities."   Third  quarter financial results and recent … 5 percent operational Announced Pharmaceuticals and Medical Device Agency … per share data) Gross  Profit Operating  Expenses Operating  Income … 0 % ~15.5% Earnings per Share Q4 2025 …

… . Don’t overlook its earnings date of Wednesday, October … . The pharma giant and household name issued strong profit numbers last … heading into the October 14 third-quarter release, and the bulls … somewhat swollen price-to-earnings ratio just below 18x …

… the company reported downbeat third-quarter financial results Tuesday after … market close. Netflix reported third-quarter revenue of $11.51 … Pro. The company reported earnings per share of $5 … declining 5% on Tuesday. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) …

… conference call to discuss the third quarter earnings for 2025. My name is … 3, the third quarter reflected continued momentum in our core earnings. Relative to … NDFIs for health care and pharmaceuticals, but there are also some …